31. IDF Education Modules 2011
المراجع
Amiel, S. Hypoglycemia: from the laboratory to the clinic. Diabetes Care 2009; 32 : 1364-1371.
Bolli, G.B. How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1
diabetes. Diabetes Care 1999; 22: B43–B52.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes
Association 2008. Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
Canadian Journal of Diabetes 2008 ; 32 suppl 1.
Cox, D.J., Gonder-Frederick, L.A., Kovatchev, B.P., Julian, D.M., Clarke, W.L. Progressive
hypoglycaemia's impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care 2000;
23(2): 163-70.
Cox, D.J., Gonder-Frederick, L., Polonsky. W., Schlundt, D., Kovatchev, B., Clarke, W. Blood glucose
awareness training (BGAT-2): Long-term benefits. Diabetes Care 2001; 24(4) : 637-42.
Cryer, P.E., Davis, S.N., Shamoon, H. Hypoglycemia in diabetes. Diabetes Care 2003; 26(6):1902-1912.
DCCT. The effect of intensive treatment of diabetes on the development and progression of long-term
complications in insulin dependent diabetes mellitus. N Eng J Med 1993; 329(14): 977-86.
Fowler, M.J. Hypoglycemia. Clinical Diabetes 2008; 26(4): 170-173.
Frier AKV, Nocturnal Hypoglycemia: clinical manifestations and therapeutic strategies toward prevention.
Endocr Pract 2003; 9(6): 530-43.
Garg, S.K., Gottlieb, P.A., Hisamoti, M.E., D’Souza, A., Walker, A.J., Izuora, K.E., et al. Improved glycemic
control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving
morning, evening, or split doses insulin glargine. Diabetes Res Clin Pract 2004; 66(1); 49-56.
Garg, S.K., Paul, J.M., Karsten, J.I., Menditto, L., Gottlieb, P.A. Reduced severe hypoglycemia with insulin glargine in
intensively treated adults with type 1 diabetes. Diabetes Technol Ther 2004; 6(5): 589-95.
Module4 - 1 | Hypoglycaemia 31
32. IDF Education Modules 2011
المراجع
Johnson, E.L., Brosseau, J.D., Sobule, M., Kolberg, J. Treatment of diabetes in long-term care
facilities: A primary care approach. Clinical Diabetes 2009; 26(4): 152-156.
Jones, T.W., Porter, P., Sherwin, R.S., Davis, E.A., O’Leary, P., Frazer, F., Byrne, G., Stick, S., et al. Decreased
epinephrine responses to hypoglycaemia during sleep. N Eng J Med 1998; 338: 1657-62.
Leiter, L.A., Yale, J.F., Chiasson J.L., Harris, S.B., Kleinstiver, P., Sauriol, L. Assessment of the impact
of fear of hypoglycemic events. Can J Diabetes 2005; 29(3): 186-192.
Rosenstock, J., Dailey, G., Massi-Benedetti, M., Fritsche, A., Lin, Z., Salzman, A. Reduced
hypoglycemia risk with insulin glargine: A meta-analysis comparing insulin glargine with human NPH insulin in type 2
diabetes. Diabetes Care 2005; 28(4): 950-5.
Saleh M., Grunberger, G. Hypoglycemia: A cause for poor glycemic control. Clinical Diabetes, 2001; 19(4): 161-167.
The Diabetes Control and Complications Trial Research Group. Effects of intensive diabetes therapy on
neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 1996; 124: 379-
88.
Thomas, R.M., Aldibbiat A., Griffin, W., Cox, M.A., Leech, N.J., Shaw, J.A. A randomized pilot study in type 1
diabetes complicated by severe hypoglycaemia, comparing rigorous avoidance with insulin analogue therapy, CSII or
education alone. Diabetic Medicine 2007; 24(7):778-83.
Turner, B.C., Jenkins, E., Kerr, D., Sherwin, R.S., Cavan, D.A. The effect of evening alcohol consumption on
next-morning glucose control in type 1 diabetes. Diabetes Care 2001; 24(11): 1888-93.
UKPDS. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment
and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352(9131): 837-53.
Zammitt, N.N., Frier, B.M. Hypoglycemia in type 2 diabetes. Diabetes Care 2005; 28(12): 2948-2961.
Module4 - 1 | Hypoglycaemia 32